Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
12.6%
% of IYH's 106 holdings also in MEDX
43.3%
% of MEDX's 30 holdings also in IYH
Overlap by Weight
Sector Drift (IYH minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IYH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.8% | 16.4% | 11.8% |
|
ABBVIE INC | 5.7% | 8.2% | 5.7% |
|
JOHNSON & JOHNSON | 6.6% | 4.6% | 4.6% |
|
MERCK & CO. INC. | 4.8% | 4.2% | 4.2% |
|
AMGEN INC | 2.7% | 5.6% | 2.7% |
Position Highlights (Non-Overlapping Exposures)
IYH Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 8.9% |
|
THERMO FISHER SCIENTIFIC INC | 3.8% |
|
ABBOTT LABORATORIES | 3.7% |
|
INTUITIVE SURGICAL INC | 3.6% |
|
DANAHER CORP | 2.8% |
|
STRYKER CORP | 2.5% |
|
BOSTON SCIENTIFIC CORP | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.2% |
|
GILEAD SCIENCES INC | 2.1% |
 |
MEDTRONIC PLC | 2.0% |
IYH Underweight Relative to MEDX
 |
NOVARTIS AG-ADR | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.1% |
|
ELI LILLY & CO | -4.6% |
|
ALKERMES PLC | -4.3% |
|
BRISTOL-MYERS SQUIBB CO | -4.0% |
|
ALNYLAM PHARMACEUTICALS INC | -3.8% |
|
AMGEN INC | -2.9% |
|
CRISPR THERAPEUTICS AG | -2.9% |
|
IONIS PHARMACEUTICALS, INC. | -2.7% |
|
ABBVIE INC | -2.5% |